Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia01:30

Dementia

97
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
97
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

58
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
58
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

448
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
448
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

165
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

98
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
98
Documentation in Long-Term and Home Healthcare Setting01:29

Documentation in Long-Term and Home Healthcare Setting

873
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
873

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Navigating an unpredictable supply: lived experiences of xylazine exposure among people who use drugs.

Harm reduction journal·2026
Same author

Navigating an Unpredictable Supply: Lived Experiences of Xylazine Exposure Among People Who Use Drugs.

Research square·2026
Same author

Integrating Lifestyle and Obesity Medicine into Residency Education: A Clinical-Educational Model in an Underserved Setting.

American journal of lifestyle medicine·2025
Same author

A dataset of windows malware execution traces.

Data in brief·2025
Same author

Apolitical Science.

Environmental science & technology·2025
Same author

Activity Restrictions After Midurethral Sling: A Randomized Controlled Trial.

Urogynecology (Philadelphia, Pa.)·2025
Same journal

The Impacts of a Primary Care-Based Dietitian Health Coaching Intervention on Patients' Health: An Observational Study.

American journal of lifestyle medicine·2026
Same journal

Putting What Matters First: A Case-Based Approach to Goal Setting to Promote Older Adult Brain Health in the AgeWISE-Action Plan Program.

American journal of lifestyle medicine·2026
Same journal

Assessing the Feasibility and Acceptability of VA Whole Health Coaching Among Veterans With Complex Health Care Needs-A Pilot Study.

American journal of lifestyle medicine·2026
Same journal

Leveraging Wearable Technology to Support Behavior Change in Personalized Nutrition and Lifestyle Medicine.

American journal of lifestyle medicine·2026
Same journal

AJLM Launches a Lifestyle Medicine in Asia Section.

American journal of lifestyle medicine·2026
Same journal

Species Extinction, Biodiversity, Human Health, and Inevitable Role of Lifestyle Medicine: A Narrative Review.

American journal of lifestyle medicine·2026
See all related articles

Related Experiment Video

Updated: Jun 7, 2025

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

7.3K

Dementia and Cognitive Decline: A HEALM Approach.

Ecler E Jaqua1, Mai-Linh N Tran1, Pedro Alvarez1

  • 1Family Medicine Department, Loma Linda University School of Medicine, Loma Linda, CA, USA (EJ, MLT, PA, MG).

American Journal of Lifestyle Medicine
|November 14, 2024
PubMed
Summary
This summary is machine-generated.

Lifestyle medicine interventions like diet and exercise can significantly reduce dementia risk. This review highlights evidence-based strategies for cognitive health and aging well.

Keywords:
cognitive declinedementialifestyle medicinemeta-analysispreventionqualityrandomized trials

More Related Videos

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.5K
Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
10:13

Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach

Published on: February 14, 2014

13.7K

Related Experiment Videos

Last Updated: Jun 7, 2025

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

7.3K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.5K
Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
10:13

Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach

Published on: February 14, 2014

13.7K

Area of Science:

  • Gerontology
  • Public Health
  • Neurology

Background:

  • Dementia and cognitive decline represent escalating global health concerns.
  • Lifestyle medicine, encompassing diet, exercise, sleep, social connection, stress management, and substance avoidance, offers potential mitigation strategies.
  • Traditional research methods like randomized controlled trials (RCTs) have limitations in assessing long-term lifestyle intervention effects.

Purpose of the Study:

  • To evaluate the impact of lifestyle factors on dementia and cognitive decline using the HEALM framework.
  • To integrate diverse evidence sources for a comprehensive assessment of lifestyle interventions.
  • To inform public health strategies for addressing cognitive aging.

Main Methods:

  • Development of the Hierarchies of Evidence Applied to Lifestyle Medicine (HEALM) framework by the American College of Lifestyle Medicine (ACLM) and True Health Initiative (THI).
  • Utilizing the Evidence Threshold Pathway Mapping (ETPM) approach to inform the HEALM framework.
  • Review and synthesis of evidence on lifestyle interventions' effects on cognitive health.

Main Results:

  • Strong evidence supports plant-based nutrition, physical activity, restorative sleep, and avoiding risky substances for cognitive health.
  • Social connections show potential in mitigating cognitive decline.
  • Findings for stress management remain inconclusive, requiring further investigation.

Conclusions:

  • Lifestyle interventions are crucial for promoting cognitive health and managing dementia risk.
  • Integrating evidence-based lifestyle strategies into public health initiatives can combat the rising dementia burden.
  • Continued research is essential to further elucidate the role of lifestyle in cognitive well-being and aging.